DIMETHYL FUMARATE TEVAPHARM gastroresistentne kõvakapsel Eesti - eesti - Ravimiamet

dimethyl fumarate tevapharm gastroresistentne kõvakapsel

teva gmbh - dimetüülfumaraat - gastroresistentne kõvakapsel - 120mg 100tk; 120mg 14tk

APIXABAN TEVAPHARM õhukese polümeerikattega tablett Eesti - eesti - Ravimiamet

apixaban tevapharm õhukese polümeerikattega tablett

teva gmbh - apiksabaan - õhukese polümeerikattega tablett - 5mg 60tk; 5mg 56tk; 5mg 28tk; 5mg 100tk

APIXABAN TEVAPHARM õhukese polümeerikattega tablett Eesti - eesti - Ravimiamet

apixaban tevapharm õhukese polümeerikattega tablett

teva gmbh - apiksabaan - õhukese polümeerikattega tablett - 2,5mg 168tk

DIMETHYL FUMARATE TEVAPHARM gastroresistentne kõvakapsel Eesti - eesti - Ravimiamet

dimethyl fumarate tevapharm gastroresistentne kõvakapsel

teva gmbh - dimetüülfumaraat - gastroresistentne kõvakapsel - 240mg 168tk

Comirnaty Euroopa Liit - eesti - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaktsiinid - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. kasutamist see vaktsiin peaks olema kooskõlas ametlike soovitustega.

RevitaCAM Euroopa Liit - eesti - EMA (European Medicines Agency)

revitacam

zoetis belgium sa - meloksikaam - oxicams - koerad - põletiku ja valu leevendamine koertel nii ägedate kui ka krooniliste lihas-skeleti kahjustuste korral.

Furosoral vet tablett Eesti - eesti - Ravimiamet

furosoral vet tablett

le vet. beheer b.v. - furosemiid - tablett - 40mg 30tk

Metrobactin vet tablett Eesti - eesti - Ravimiamet

metrobactin vet tablett

dechra regulatory b.v. - metronidasool - tablett - 250mg 500tk; 250mg 60tk; 250mg 250tk; 250mg 90tk; 250mg 100tk; 250mg 1000tk

Canizol vet tablett Eesti - eesti - Ravimiamet

canizol vet tablett

dechra regulatory b.v. - ketokonasool - tablett - 400mg 50tk; 400mg 70tk; 400mg 90tk; 400mg 10tk; 400mg 60tk; 400mg 80tk; 400mg 30tk; 400mg 40tk; 400mg 100tk

Canizol vet tablett Eesti - eesti - Ravimiamet

canizol vet tablett

dechra regulatory b.v. - ketokonasool - tablett - 200mg 60tk; 200mg 90tk; 200mg 30tk; 200mg 50tk; 200mg 80tk; 200mg 40tk; 200mg 10tk; 200mg 20tk; 200mg 100tk; 200mg 70tk